WHO ICTRP trial
Monitoring of dabigatran and direct factor xa inhibitors in patients undergoing…
DRKS00033670 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00033670 |
|---|---|
| Public title | Monitoring of dabigatran and direct factor xa inhibitors in patients undergoing surgery: a prospective study |
| Scientific title | Monitoring of dabigatran and direct factor xa inhibitors in patients undergoing surgery: a prospective study |
| Primary sponsor | Universitätsklinikum Carl Gustav Carus Dresden |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | Z92.1;Personal history of long-term (current) use of anticoagulants;Z92.1 |
| Interventions | Group 1: intake of Dabigatran, Edoxaban, Rivaroxaban oder Apixaban within 48 h prior to surgery Group 2: application of low-molecular-weight heparin (LMWH)t within 48 h prior to surgery |
| Registration date | Mar 18, 2024 |
| Target size | 500 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: